You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023178016
Dec 20236906
Jan 20245607
Feb 20246201
Mar 20243004
Apr 20243401
May 20241201
Jun 20242601
Jul 20241802
Aug 20243402
Sep 20245203
Oct 20242203
Nov 20245203
Dec 202436011
Jan 202548010
Feb 20251007
Mar 2025007
Apr 2025102
May 2025005
Jun 2025004
Total740096